These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2442006)

  • 1. Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain.
    Hagan RM; Butler A; Hill JM; Jordan CC; Ireland SJ; Tyers MB
    Eur J Pharmacol; 1987 Jun; 138(2):303-5. PubMed ID: 2442006
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.
    Hagan RM; Jones BJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1990 Feb; 99(2):227-32. PubMed ID: 1691672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens.
    Chen JP; van Praag HM; Gardner EL
    Brain Res; 1991 Mar; 543(2):354-7. PubMed ID: 1711914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
    Koulu M; Sjöholm B; Lappalainen J; Virtanen R
    Eur J Pharmacol; 1989 Oct; 169(2-3):321-4. PubMed ID: 2530097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 5-HT3 receptor-selective agents on locomotor activity in rats following injection into the nucleus accumbens and the ventral tegmental area.
    Gillies DM; Mylecharane EJ; Jackson DM
    Eur J Pharmacol; 1996 May; 303(1-2):1-12. PubMed ID: 8804905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.
    Koulu M; Lappalainen J; Hietala J; Sjöholm B
    Psychopharmacology (Berl); 1990; 101(2):168-71. PubMed ID: 2140903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural effects of tachykinins and related peptides.
    Elliott PJ; Iversen SD
    Brain Res; 1986 Aug; 381(1):68-76. PubMed ID: 2428433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioural effects of a novel substance P analogue following infusion into the ventral tegmental area or substantia nigra of rat brain.
    Eison AS; Eison MS; Iversen SD
    Brain Res; 1982 Apr; 238(1):137-52. PubMed ID: 6177380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical consequences following injection of the substance P analogue, DiMe-C7, into the rat ventral tegmental area.
    Barnes JM; Barnes NM; Costall B; Cox AJ; Domeney AM; Kelly ME; Naylor RJ
    Pharmacol Biochem Behav; 1990 Dec; 37(4):839-41. PubMed ID: 1709506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal sites mediating locomotor hyperactivity following central neurokinin agonist administration.
    Elliott PJ; Paris JM; Mitsushio H; Lorens SA
    Pharmacol Biochem Behav; 1990 Oct; 37(2):329-33. PubMed ID: 1706862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse.
    Costall B; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB
    Br J Pharmacol; 1989 Feb; 96(2):325-32. PubMed ID: 2522335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GR38032F, a serotonin 5-HT3 antagonist, fails to alter cocaine self-administration in rats.
    Peltier R; Schenk S
    Pharmacol Biochem Behav; 1991 May; 39(1):133-6. PubMed ID: 1833779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
    Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
    Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study.
    Yan QS; Yan SE
    Eur J Pharmacol; 2001 Apr; 418(1-2):55-64. PubMed ID: 11334865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of accumbens 5-HT3 receptor down-regulation by ondansetron administered during continuous cocaine administration.
    King GR; Xiong Z; Ellinwood EH
    Eur J Pharmacol; 1999 Jan; 364(2-3):79-87. PubMed ID: 9932709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats.
    Imperato A; Angelucci L
    Neurosci Lett; 1989 Jun; 101(2):214-7. PubMed ID: 2549462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.
    Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance-P antagonists: effect on spontaneous and drug-induced locomotor activity in the rat.
    Elliott PJ; Iversen SD
    Neuropharmacology; 1987 May; 26(5):419-22. PubMed ID: 2439936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.